Kunming Biomed International
PrivateCompany Overview
Kunming Biomed International is a contract research organization (CRO) that provides preclinical research services specializing in non-human primate (NHP) disease models for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kunming Biomed International Comparables
Compare Kunming Biomed International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prisys Biotechnology Co., Ltd. | 88% | |
| Virscio | 88% | |
| Cynbiose | 88% | |
Kunming Biomed International Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2023
Grew 36% QoQ, from 11 to 15 employees.
- Nov 15, 2023
Grew 27% QoQ, from 11 to 14 employees.
Kunming Biomed International Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kunming Biomed International's valuation, stock price, and market status.